-+ 0.00%
-+ 0.00%
-+ 0.00%

Virax Biolabs to consolidate shares 1-for-25 on June 26

PUBT·06/24/2026 13:02:23
Listen to the news
Virax Biolabs to consolidate shares 1-for-25 on June 26
  • Virax Biolabs set a 1-for-25 share consolidation effective June 26, 2026.
  • Shares will trade post-consolidation on Nasdaq under VRAX at the open, with CUSIP G9495L133.
  • Move targets Nasdaq’s $1 minimum bid rule to maintain its Nasdaq Capital Market listing.
  • Each 25 ordinary shares at US$ 0.001 par value converts into 1 share at US$ 0.025; fractions round up.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606240900PR_NEWS_USPR_____DA90168) on June 24, 2026, and is solely responsible for the information contained therein.